What Is PMOS? Symptoms, Diagnosis, and the Insulin Resistance Connection

Written by Kerri Rachelle, PhD(c), RDN, CSSD, FMP-AC
Founder & CEO, REV0lution | Doctor of Integrative & Natural Medicine Candidate

Quick Answer

PMOS—polyendocrine metabolic ovarian syndrome—is the new name for the condition formerly called polycystic ovary syndrome, or PCOS. It is a complex endocrine, metabolic and ovarian syndrome that can affect androgen activity, ovulation, menstrual cycles, insulin sensitivity, glucose regulation, fertility and long-term health.

PMOS is not simply a problem of ovarian “cysts,” and cysts are not required for diagnosis. It can occur in women of any body size, including women who are lean. Insulin resistance is an important driver for many women with PMOS, but it is not the only cause or present in exactly the same way in every person.

Diagnosis requires an appropriate clinical evaluation and the exclusion of other conditions that can cause similar symptoms. Treatment should address the individual woman’s endocrine, metabolic, reproductive and psychological health—not simply tell her to lose weight.

Key Takeaways

• PMOS is the new name for PCOS.

• It is a whole-body endocrine and metabolic syndrome—not simply an ovarian or fertility condition.

• Ovarian “cysts” are generally developing follicles and are not required for diagnosis.

• Symptoms may include irregular periods, difficulty ovulating, acne, increased facial or body hair, scalp hair thinning and metabolic changes.

• Insulin resistance is common in PMOS, but it is not universal.

• PMOS can occur in women of any body size.

• Normal fasting glucose does not necessarily rule out earlier insulin dysregulation.

• Diagnosis requires clinical interpretation and the exclusion of other possible causes.

• Treatment may include real-food nutrition, movement, muscle development, sleep support, stress management and medication.

• Intermittent fasting may help some women, but it is not a universal PMOS treatment.

A woman may first hear about PMOS after years of irregular periods. Another may seek care for acne, facial hair or difficulty becoming pregnant. Someone else may be told to lose weight after an elevated glucose or insulin result, while a lean woman may struggle to get evaluated at all because she does not fit the stereotype.

These symptoms can appear reproductive, cosmetic or metabolic, but they may be different expressions of the same interconnected syndrome.

In May 2026, polycystic ovary syndrome was officially renamed polyendocrine metabolic ovarian syndrome, or PMOS. The new name reflects a much broader understanding of the condition. PMOS is not primarily about ovarian cysts, and it does not begin and end with fertility. It can affect endocrine signaling, metabolism, glucose regulation, cardiovascular risk, mental health, skin, hair, menstruation and quality of life.

What Is PMOS, Formerly Known as PCOS?

PMOS stands for polyendocrine metabolic ovarian syndrome. Each part of the name helps explain the condition more accurately.

Polyendocrine recognizes that multiple hormone systems and signaling pathways may be involved. Metabolic brings attention to insulin, glucose regulation, lipids, blood pressure and long-term metabolic health. Ovarian preserves the important reproductive features, including follicle development, ovulation, menstruation and fertility. Syndrome means that the features can appear in different combinations rather than following one identical pattern in every woman.

PMOS is not one hormone imbalance with one universal cause. It is a heterogeneous syndrome shaped by interactions among genetics, androgen signaling, ovarian function, insulin regulation, body composition, sleep, activity, medications, life stage and other environmental influences.

This is why two women with the same diagnosis can have very different symptoms, laboratory findings and treatment needs.

What Happens in PMOS?

Three interconnected areas usually define the clinical picture: androgen activity, ovulatory or ovarian function, and metabolic health.

Androgens are often called “male hormones,” but women naturally produce and need them too. In PMOS, androgen levels or androgen activity may become elevated. This can appear as persistent acne, increased facial or body hair, scalp hair thinning, oily skin, irregular ovulation or unpredictable menstrual cycles. Androgen excess may be identified through symptoms, laboratory testing or both.

Ovulatory dysfunction occurs when an egg is not released consistently. A woman may have long menstrual cycles, skip periods, experience unpredictable bleeding or bleed somewhat regularly without consistently ovulating. This matters for fertility, but it also matters when pregnancy is not a current goal. Prolonged periods without ovulation can affect endometrial health and should not be dismissed as merely inconvenient.

The metabolic features may be less obvious. Some women experience difficulty regulating weight, strong hunger, fatigue after meals or darkened, velvety patches of skin called acanthosis nigricans. Laboratory testing may reveal elevated fasting insulin, impaired glucose tolerance, prediabetes or abnormal lipids. None of these findings diagnoses PMOS by itself, but together they may reveal a metabolic pattern that deserves attention.

What Are the Symptoms of PMOS?

PMOS does not look the same in every woman. Symptoms may include irregular, infrequent or absent periods; difficulty ovulating; fertility challenges; unpredictable bleeding; acne; increased facial or body hair; and scalp hair thinning.

Some women present primarily with metabolic concerns, including insulin resistance, elevated glucose, abnormal lipids or difficulty regulating weight. Others have visible androgen-related symptoms but relatively normal glucose markers. A woman may also have polycystic ovarian morphology on ultrasound without experiencing the full syndrome.

PMOS can affect mental health and quality of life as well. Anxiety, depression, eating-disorder risk, body-image distress and the emotional burden of delayed diagnosis deserve attention. These are not secondary concerns that should be dismissed once menstrual cycles are addressed.

Symptoms can also change with age, medication, pregnancy, changes in body composition and the transition into perimenopause. PMOS is often discussed as a reproductive-age condition, but its metabolic consequences do not automatically disappear when fertility is no longer the primary concern.

Why Does PMOS Present Differently in Different Women?

One woman may seek care because she has not had a period in four months. Another may have somewhat predictable cycles but significant acne and facial hair. A third may have few visible androgen symptoms but elevated insulin, prediabetes and difficulty regulating weight.

These women may not have identical underlying drivers, even if they meet the same diagnostic framework.

Genetics, insulin sensitivity, androgen production, ovarian signaling, muscle mass, sleep, stress, medication and life stage can all shape the presentation. Higher body fat may amplify metabolic or reproductive symptoms for some women, but it is not required for PMOS and is not always the underlying cause.

Symptom variation does not mean the condition is imaginary, and a woman does not need to display every possible feature to deserve a complete evaluation.

How Is PMOS Diagnosed?

There is no single blood test, ultrasound or symptom that diagnoses PMOS.

In adults, diagnosis generally requires two of three features after other possible causes have been excluded:

1. Clinical or biochemical hyperandrogenism

2. Ovulatory dysfunction

3. Polycystic ovarian morphology, with anti-Müllerian hormone used in specific adult diagnostic contexts

These are not boxes that should be checked without clinical interpretation. Cycle history matters. The quality and timing of laboratory testing matter. Medication can affect hormone results, and ultrasound findings must be considered alongside symptoms rather than treated as the complete diagnosis.

A clinician may also need to consider pregnancy, thyroid dysfunction, elevated prolactin, nonclassic congenital adrenal hyperplasia, hypothalamic amenorrhea, Cushing syndrome, androgen-secreting tumors, perimenopause and medication effects. Testing should be guided by the woman’s presentation—not ordered indiscriminately.

Diagnosis during adolescence requires particular care. Irregular cycles, acne and changing ovarian morphology can overlap with normal puberty. Adult ultrasound rules should not be casually applied to teenagers, and neither overdiagnosis nor dismissal serves the patient.

Do You Need Ovarian Cysts to Have PMOS?

No. Ovarian cysts are not required for PMOS.

The structures historically described as “cysts” are generally developing ovarian follicles—not the same as pathological ovarian cysts. Some women with PMOS have an increased number of follicles or increased ovarian volume, while others have normal-appearing ovaries on ultrasound.

A normal ultrasound does not automatically rule out PMOS. Conversely, polycystic ovarian morphology on an ultrasound does not necessarily mean a woman has the complete syndrome.

This is one of the most important reasons the name changed. Ovarian appearance is one possible feature—not the definition of the condition.

What Is the Connection Between PMOS and Insulin Resistance?

Insulin resistance occurs when cells do not respond to insulin as effectively as they should. The pancreas may compensate by producing more insulin to keep glucose within an acceptable range.

This compensation can hide the problem for a time. A woman may have normal fasting glucose or A1C while her body is using increasingly higher insulin levels to maintain those results.

In PMOS, elevated insulin can interact with ovarian and androgen signaling. It may stimulate ovarian androgen production and reduce sex hormone-binding globulin, increasing the amount of biologically active androgen in circulation. That can worsen acne, hair changes, ovulatory dysfunction and menstrual irregularity while also increasing long-term metabolic risk.

This can create an amplifying loop: insulin resistance contributes to elevated insulin, elevated insulin can intensify androgen activity, and those hormonal and metabolic changes may make appetite, body composition and glucose regulation more difficult.

However, insulin resistance is not the sole cause of every case. PMOS should not simply be renamed “insulin-resistance syndrome,” and women without obvious insulin resistance should not be dismissed.

Can Insulin Be Elevated Before Glucose?

Yes. Insulin may rise before fasting glucose or A1C becomes abnormal because the pancreas is working harder to keep glucose controlled.

That is why fasting insulin may sometimes provide useful metabolic context. It is not, by itself, a diagnostic test for PMOS, and there is no universally accepted fasting-insulin cutoff that confirms the condition. It should be interpreted alongside glucose markers, symptoms, medications, medical history and other findings.

Depending on the individual, evaluation may include fasting glucose, A1C, an oral glucose tolerance test, fasting insulin, lipids, blood pressure and other targeted testing. A glucose tolerance test may reveal impaired regulation that fasting glucose alone misses.

Because PMOS is associated with an increased risk of impaired glucose regulation, women should also understand what prediabetes means—and why waiting for glucose to reach the diabetes range is not an adequate prevention strategy.

Can You Have PMOS Without Being Overweight?

Yes. PMOS occurs across body sizes.

Lean women may still experience androgen excess, irregular ovulation, insulin resistance and increased metabolic risk. Higher body fat can intensify metabolic and reproductive symptoms for some women, but it is not required for PMOS and is not always the underlying cause. Genetics, androgen signaling, ovarian function, insulin regulation and other endocrine factors can contribute independently of body size.

Some women with PMOS may benefit metabolically from losing excess body fat, but that does not make “lose weight” an adequate treatment plan. Weight regulation may itself be complicated by insulin resistance, poor sleep, medication effects, appetite dysregulation and hormonal symptoms.

Assuming that PMOS only affects women in larger bodies—or telling a woman simply to eat less—can delay diagnosis, overlook the drivers of her symptoms and deny her comprehensive care. If weight is difficult to regulate despite repeated effort, the answer to “Why can’t I lose weight?” may involve far more than willpower or calorie tracking.

PMOS should never be ruled out because a woman is thin, and “lose weight” should never substitute for a complete evaluation.

Does PMOS Affect Long-Term Health?

PMOS is not only relevant while a woman is trying to become pregnant. It can have implications for glucose regulation, type 2 diabetes risk, blood pressure, lipids, sleep apnea, endometrial health, mental health and metabolic dysfunction-associated steatotic liver disease.

The condition is also associated with an unfavorable cardiovascular risk profile. That does not mean every woman with PMOS will develop cardiovascular disease. It means the diagnosis should prompt appropriate screening and prevention rather than fear-based certainty.

Understanding metabolic health requires looking beyond weight or one glucose result. Blood pressure, lipids, glucose regulation, insulin sensitivity, body composition, physical activity, sleep and family history all contribute to the larger picture.

Can Intermittent Fasting Help PMOS?

Intermittent fasting may help some women establish a more consistent eating rhythm, reduce late-night eating or improve selected metabolic markers. It is an option—not a requirement.

A 2026 randomized controlled trial published in Nature Medicine followed 76 women with PCOS for six months. Participants were assigned to a six-hour eating window from 1 p.m. to 7 p.m. without calorie tracking, a plan prescribing a 25% daily calorie reduction, or a control group that made no dietary changes.

The time-restricted group lost approximately 4.3% of body weight, while the calorie-restriction group lost approximately 4.7%. Both approaches outperformed the control group, but there was no meaningful difference in weight loss between time-restricted eating and daily calorie restriction.

The study also evaluated insulin-related and androgen outcomes, but it did not prove that fasting is metabolically superior or that every woman with PMOS should use a six-hour eating window. It was a relatively small, six-month trial, and participants received regular nutrition counseling from a dietitian.

The more useful interpretation is that time-restricted eating may offer an alternative to daily calorie counting for some women. If an eating window improves consistency without causing under-fueling, intense hunger, poor sleep, food preoccupation, menstrual disruption or rebound eating, it may be helpful. If it makes a woman feel worse, she should not force it simply because she has insulin resistance or PMOS.

The evidence on intermittent fasting for women supports an individualized approach. Fasting is not a moral achievement, and a longer fast is not automatically a better treatment.

How Is PMOS Treated?

PMOS treatment should reflect the woman’s symptoms, metabolic health, life stage, pregnancy intentions and personal goals. There is no single treatment or diet that is appropriate for everyone.

REV0lution recommends building PMOS nutrition around meaningful real-food protein, fiber-rich vegetables and other whole plants, naturally occurring fats and an individualized amount of whole-food carbohydrate. Carbohydrate quality, quantity and distribution may need adjustment when insulin resistance is present, but PMOS does not require the elimination of carbohydrates or a restrictive eating plan. Meals should provide adequate nourishment to support stable energy, muscle, hormonal health and a sustainable relationship with food.

Artificially sweetened shakes, protein bars, packaged keto desserts and other manufactured substitutes should never become the foundation of nutrition. “Zero sugar” does not mean healthy, and matching calories or macronutrients does not make an ultra-processed product nutritionally equivalent to real food.

Movement also matters. Resistance training can support muscle development, and muscle is an important site of glucose disposal. Walking, cardiovascular activity and breaking up prolonged sitting can support metabolic health without turning exercise into punishment for body weight.

Sleep, stress and mental health require equal attention. Inadequate sleep can complicate glucose regulation, appetite and recovery, while sleep apnea may go undetected. Stress does not single-handedly cause PMOS, but it can affect how symptoms are experienced and managed.

Medication may be appropriate for menstrual regulation, endometrial protection, insulin sensitivity, ovulation, androgen-related symptoms, weight management or fertility. Medication is not evidence that real-food nutrition failed, and it should never be stopped to satisfy a clean-eating or functional-medicine ideal.

A functional medicine registered dietitian can help connect symptoms, laboratory findings, food quality, glucose regulation, medications and individual preferences without reducing the entire plan to weight loss.

The Bottom Line

PMOS is not simply a cyst problem, fertility diagnosis or consequence of body weight. It is a whole-body syndrome that can involve androgen signaling, ovulation, insulin regulation, glucose metabolism, mental health and long-term cardiometabolic risk.

Insulin resistance is an important driver for many women, but it is not the only driver and should not become a new oversimplification. Ovarian cysts are not required. Excess body weight is not required. Difficulty becoming pregnant is not required.

The new name gives women and clinicians a more accurate framework for understanding the condition. But the terminology will only improve health if it helps patients understand the underlying drivers of their symptoms—and if care changes with it.

Medical Disclaimer: This article is for general educational and informational purposes only and does not provide individualized medical or nutrition advice. It is not intended to diagnose, treat, cure, or prevent disease or replace care from a qualified healthcare professional. Do not change your medications, supplements, diet, fasting schedule, or healthcare plan based solely on this content. [Read the full Medical Disclaimer and Terms & Conditions.]

Frequently Asked Questions

What is PMOS?

PMOS stands for polyendocrine metabolic ovarian syndrome. It is the new name for the condition previously called polycystic ovary syndrome, or PCOS. PMOS is a whole-body endocrine, metabolic and ovarian syndrome that can affect androgen activity, ovulation, menstrual cycles, insulin sensitivity, glucose regulation, fertility, skin, hair and long-term health.

Is PMOS the same condition as PCOS?

Yes. PMOS is the new name for the condition historically called PCOS. The condition did not suddenly become a different disease, and women previously diagnosed with PCOS do not need to be rediagnosed solely because the name changed. The new terminology more accurately reflects the condition’s endocrine, metabolic and reproductive features.

Why was PCOS renamed PMOS?

The name polycystic ovary syndrome incorrectly suggested that ovarian cysts defined the condition. The structures commonly seen on ultrasound are generally developing follicles—not pathological cysts—and they are not required for diagnosis. The name PMOS recognizes that the syndrome can involve multiple hormone systems, metabolism, glucose regulation, ovarian function and health beyond fertility.

What are the most common PMOS symptoms?

PMOS symptoms may include irregular, infrequent or absent periods; difficulty ovulating; acne; increased facial or body hair; scalp hair thinning; oily skin; unpredictable bleeding and fertility challenges. Some women also experience insulin resistance, elevated fasting insulin, impaired glucose tolerance, abnormal lipids or difficulty regulating weight. Symptoms vary, and a woman does not need to experience every possible feature.

How is PMOS diagnosed?

In female adults, PMOS diagnosis generally requires two of three features after other possible causes have been excluded:

1. Clinical or biochemical hyperandrogenism

2. Ovulatory dysfunction

3. Polycystic ovarian morphology, with AMH used in specific adult diagnostic contexts

There is no single blood test, symptom or ultrasound finding that diagnoses PMOS by itself.

Do you need ovarian cysts to have PMOS?

No. Ovarian cysts are not required for diagnosis. A woman may meet diagnostic criteria through ovulatory dysfunction and hyperandrogenism without polycystic ovarian morphology. A normal ultrasound therefore does not automatically rule out PMOS.

Can you have polycystic ovaries without having PMOS?

Yes. Some women have polycystic ovarian morphology on ultrasound without experiencing the broader endocrine and reproductive features required for PMOS. An ultrasound finding must be interpreted alongside menstrual history, androgen-related symptoms, laboratory results and the complete clinical picture.

Can you have PMOS with regular periods?

Possibly. Apparently regular bleeding does not always confirm that ovulation is occurring consistently. Some women also have androgen-related or metabolic features despite having relatively predictable cycles. Diagnosis requires an individualized evaluation rather than relying on cycle regularity alone.

What is the connection between PMOS and insulin resistance?

Insulin resistance is common in PMOS. When cells respond less effectively to insulin, the pancreas may produce more insulin to keep glucose controlled. Elevated insulin can stimulate ovarian androgen production and reduce sex hormone-binding globulin, increasing biologically active androgen. This may intensify acne, hair changes, ovulatory dysfunction and metabolic risk. However, insulin resistance is not the sole cause of every PMOS case.

Can insulin be elevated when fasting glucose is normal?

Yes. The pancreas may compensate for insulin resistance by producing more insulin before fasting glucose or A1C becomes abnormal. This is why fasting insulin may sometimes provide additional metabolic context. It does not diagnose PMOS by itself and must be interpreted alongside symptoms, glucose markers, medications and medical history.

Can lean women have PMOS?

Yes. PMOS occurs across body sizes. Lean women may still experience androgen excess, irregular ovulation, insulin resistance and increased metabolic risk. Higher body fat may amplify symptoms for some women, but it is not required for PMOS and is not always the underlying cause.

Does PMOS make it harder to lose weight?

It can. Insulin resistance, appetite dysregulation, poor sleep, medication effects, hormonal symptoms and differences in body composition may complicate weight regulation. However, difficulty losing weight is not required for diagnosis, and telling every woman with PMOS simply to eat less is not an adequate treatment plan.

Does PMOS always cause infertility?

No. PMOS can interfere with ovulation and make conception more difficult, but it does not mean pregnancy is impossible. Some women ovulate inconsistently, while others ovulate regularly. Fertility care should be based on the individual woman’s ovulatory function, age, medical history and reproductive goals.

What should you eat with PMOS?

There is no single mandatory PMOS diet. A strong starting point includes meaningful real-food protein, vegetables and other fiber-rich plants, naturally occurring fats and an individualized amount of whole-food carbohydrate. Carbohydrate quality, quantity and distribution may need adjustment when insulin resistance is present. However, every woman with PMOS does not need to eliminate carbohydrates or follow the same restrictive diet.

Can intermittent fasting help PMOS?

Intermittent fasting may help some women establish a consistent eating rhythm, reduce late-night eating or improve selected metabolic markers. A 2026 randomized trial found that a six-hour time-restricted eating window and daily calorie restriction produced similar weight loss in women with PCOS. This supports fasting as one possible option—not as a metabolically superior or universal treatment. Fasting should not be forced if it causes under-fueling, intense hunger, rebound eating, poor sleep, menstrual disruption or food preoccupation.

Does PMOS require medication?

Not every woman requires the same medication, but medication can be an important part of treatment. Depending on symptoms and goals, medication may support menstrual regulation, endometrial protection, insulin sensitivity, ovulation, androgen-related symptoms, weight management or fertility. Medication should not be stopped or changed without the prescribing clinician.

Does PMOS go away after menopause?

The menstrual and ovarian presentation may change, but the metabolic considerations do not automatically disappear after menopause. Glucose regulation, blood pressure, lipids, sleep, cardiovascular risk and mental health may remain relevant. PMOS should not be treated solely as a fertility condition that stops mattering after the reproductive years.

References

Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026. PMID: 42119588.

Corapi S, Runchey MC, Lyons J, et al. Time-restricted eating for body weight management in women with polycystic ovary syndrome: a randomized controlled trial. Nat Med. 2026;32:2155–2163. PMID: 41896647.

Dalamaga M, et al. What’s in a name? From PCOS to polyendocrine metabolic ovarian syndrome. 2026. PMID: 42327014.

Kordowitzki P, et al. Polyendocrine metabolic ovarian syndrome—a new name for an old problem. Nat Metab. 2026. PMID: 42237044.

Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43–G64. PMID: 37580314.

Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120(4):767–793. PMID: 37580861.

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. PMID: 29569621.

Tay CT, et al. 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline: recommendations for cardiovascular risk assessment. 2024. PMID: 39119982.

Dokras A, et al. Polycystic ovary syndrome in 2025: insights and innovations. 2025. PMID: 40992713.

Shang Y, et al. Effect of diet on insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Sci. 2020;27(9):1787–1801. PMID: 32621748.

Kazemi M, et al. Effects of dietary glycemic index and glycemic load on cardiometabolic and reproductive profiles in women with polycystic ovary syndrome: a systematic review and meta-analysis. Adv Nutr. 2021;12(1):161–178. PMID: 32805007.

Moran LJ, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013;113(4):520–545. PMID: 23420000.

Gautam R, et al. The role of lifestyle interventions in PCOS management: a systematic review. Nutrients. 2025;17(2):310. PMID: 39861440.

Teede HJ, et al. International PCOS guideline clinical research priorities for diagnosis and long-term health. 2024. PMID: 39634033.